Document is current
Any future updates will be listed below
-
Authors
Soga, Yoshimitsu https://orcid.org/0000-0003-1931-5769
Urasawa, Kazushi
Tsujimura, Takuya
Yamamoto, Yoshito
Fujihara, Masahiko
Nakama, Tatsuya
Haraguchi, Takuya
Tobita, Kazuki
-
Funding
Funding for this research was provided by:
Boston Scientific Japan
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 1 October 2025
First Online: 19 October 2025
Declarations
:
: Y.S. & K.U. are consultants for Boston Scientific and has received fees for lectures from Boston Scientific. T.T. & Y.Y. have no conflicts to report. M.F. has received fees for lectures from Boston Scientific, Medtronic, GORE, and Terumo. T.N. is a consultant for Abbott Vascular, Asahi Intecc, Becton Dickinson, Boston Scientific, Cook Medical, Cordis, Kaneka Medix, NIPRO, and OrbusNeich. T.H. has no conflicts to report. K.T. has received fees for lectures from Boston Scientific.
: The Jetstream PMS study was conducted according to Japanese Good Postmarket Surveillance Practice (GPSP) regulations using information collected from medical sites to detect or confirm the occurrence status by type of disease caused by adverse events of medical devices, as well as information on the quality, efficacy, safety, etc., of the medical device, without specifying the conditions for the patient who will be used the medical device. Consent was obtained from patients for the Jetstream procedure which included secondary use of patient data for research purposes.
